Development of a CHD risk prediction model using novel lipid markers based on lipidomics and VAP technology
Frontiers in Medicine
- Machine learning
- Lipid and ceramide metabolism
- Risk prediction model
- Coronary heart disease
- Fasting plasma glucose
- Humans
The paper
Chen X, Ning L, Chen Z et al.
Frontiers in Medicine · 26 Aug 2026
